Veterinary Diagnostics Market Size, Share & Trends Report

Veterinary Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Reagents, & Kits, Instruments & Devices), By Species (Canine, Porcine), By Testing Category, By Disease Type, By End Use, And Segment Forecasts, 2021 - 2028

  • Published Date: Jul, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-3-68038-130-6
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 165

Report Overview

The global veterinary diagnostics market size was valued at USD 6.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.5% from 2021 to 2028. The growth in this market is attributed to factors such as increased animal health expenditure, rising incidence of zoonotic diseases, number of veterinary practitioners, technological advancement in point of care diagnostics, and the disposable income levels in the developing regions.

U.S. veterinary diagnostics market size, by species, 2018 - 2028 (USD Billion)

The global outbreak of COVID-19 has impacted all industries. Currently, OIE has confirmed that no animals can spread this virus. However, human-to-animal transmission has been reported in a few countries. During the COVID-19 pandemic, limited operation of veterinary clinics due to stringent lockdown norms consequently resulted in a decline of veterinary visits, thus impacting the market. However, the market has shown a V-shaped recovery during the 3rd quarter of 2020 due to the resumption of pet clinic visits and ease of norms. According to IDEXX, U.S. clinic visits increased by 6% in Q4 2020 from the last quarter which is expected to increase the market growth over the forecast period.

Moreover, an increase in pet adoption during the pandemic is also expected to propel the market growth over the forecast period. For instance, shelters, nonprofit rescues, private breeders all reported high consumer demand post COVID-19 in the U.S. Strong product pipeline By IDEXX, Zoetis, and Heska Corporation is expected to propel the growth over the forecast period. For instance, Zoetis acquired Scandinavian Micro Biodevices in August 2020 in order to expand its revenue in veterinary diagnostics.

Veterinary Diagnostics Market: A steadily growing market, not hugely impacted by pandemic

Pandemic Impact

Post COVID Outlook

The market experienced steady growth of 10.3% from 2019 to 2020 to reach at USD 6.2 billion

Strong product pipeline By IDEXX, Zoetis and Heska Corporation is expected to propel the growth over the forecast period. For instance, Zoetis acquired Scandinavian Micro Biodevices in August

There was an increase in pet adoption reported post COVID 19 due to social isolation. For instance, shelters, nonprofit rescues, private breeders all reported high consumer demand post COVID 19 in the U.S.

Greater emphasis on vet point of care diagnostics as a preventive measure to avoid any future pandemic or zoonotic outbreak, thus propelling the growth

IDEXX's CAG diagnostics revenue increased by 23% in Q3 2020 as compared to last year

Market opportunity for new entrants. (for eg Advanced Animal Diagnostics received USD 50,000 grant from NCBiotech in 2020) which is expected to propel market growth

 

Increasing demand for point-of-care diagnostics is expected to further propel the market. It provides fast results for clinical tests and can be directly assessed to save time. According to AVMA, there were around 26,000 veterinary hospitals and clinics in the U.S. in 2019 and more than 80% of them provided point-of-care testing. In January 2020, Idexx Laboratories launched new updates for SediVue Dx Urine Sediment Analyzer, Catalyst Dx, and Catalyst One chemistry analyzers to improve its product portfolio. The aforementioned factors are expected to propel the market growth over the forecast period.

Product Insights

The consumables, reagents, and kits segment dominated the market and held the largest revenue share of over 52.0% in 2020. The market is determined by deeply understanding the demand for these products from veterinary clinics, hospitals, and labs. Moreover, there is an increasing demand for point-of-care diagnostics by pet owners.

Commonly used point of care diagnostics for companion animals are blood glucose monitors, pregnancy kits, and urinalysis strips. Whereas, for the livestock, the tests majorly remain confined to the labs owing to high sensitivity and efficacy requirements in their disease testing. The rate of consumption and usage of consumables and reagents in diagnosis is growing owing to veterinary diagnostics. This can be attributed to global increasing awareness about zoonotic diseases and a growing number of pet adoptions and concern for their health.

Species Insights

The canine segment dominated the market for veterinary diagnostics and held the largest revenue share over 34.0% in 2020. The dominant share captured by dogs is a consequence of increasing animal healthcare spending, specifically in the developed regions on pets. The increasing incidence of obesity, diabetes, cancer, and other major diseases is one of the major drivers for the market. According to an APOP report in 2019, around 57% of dogs recorded as obese in U.S. Obesity further increases the risk of joint diseases, diabetes mellitus, cancer, and other chronic conditions. The increasing concern of the pet owners resulted in regular diagnosis of glucose levels, thus increasing the market for glucose monitors.

Among the livestock, the porcine segment dominated the market as of 2020 owing to the growing consumption of pork and demand for better diagnostic procedures. The bovine segment also held a substantial share of the market owing to the increasing incidence of zoonotic diseases among cattle.

Disease Type Insights

The non-infectious diseases segment dominated the market for veterinary diagnostics and held the largest revenue share of over 27.0% in 2020. The market has demonstrated an increase in the number of diagnostics entering with innovative technologies to detect diseases in animals. For instance, the Lab on a Chip technology can analyze electrolytic imbalance in the body fluids such as urine, blood, and milk.

The hereditary, congenital, and acquired diseases segment is expected to show lucrative growth over the forecast period. These diseases are quite prevalent nowadays. The genetic disease is not clearly visible in the beginning and thus not easily diagnosed. Molecular screening is recommended for such cases.

Infectious diseases in animals are a noteworthy danger to the worldwide human and animal population and their wellbeing. These diseases should be successfully controlled to prevent epidemic and spread of infections from animal to animal or animal to humans. Few examples of prevalent animal diseases are brucellosis, influenza, foot and mouth, respiratory and reproductive, herpes, and tuberculosis.

Testing Category Insights

The pathology segment dominated the veterinary diagnostics market and accounted for the largest revenue share of over 13.0% owing to wide variety of service offerings such as various lab tests, imaging, and specialized tests. It comprises histopathology and immune histochemistry diagnostics that are used to detect changes in the tissues of animals due to a disease or medical condition. The cells can be taken from biopsy samples obtained from animals, which are processed and handed over to pathologists for further evaluation through special staining-Hematoxylin and Eosin (H&Es)-with advanced equipment. Immunohistochemistry offers markers for neoplastic and infectious diseases in small animals, such as distemper virus, adenovirus, etc., and large animals, such as BVD virus, IBR virus, and others.

Moreover, nanotechnology is the next big shot for veterinary diagnostics as it promises to screen multiple pathogens in a single assay. These advanced technologies can highly improve animal disease diagnostic capabilities while reducing the time and cost associated with conventional technologies. The molecular diagnostics segment is also expected to grow at a significant rate owing to its increased use in research purpose. Polymerase Chain Reaction (PCR) is widely used for molecular diagnosis in animals for identification and detection of various pathogens. The traditional PCR techniques are rapidly being replaced by real-time PCR. It enables the rapid identification of pathogens and provides great accuracy.

End-use Insights

The laboratories segment dominated the market for veterinary diagnostics and accounted for the largest revenue share of 37.0% in 2020 owing to the availability of a wide range of veterinary diagnostic options in these facilities. The veterinary diagnostic laboratory gives testing and results to various toxic agents, infections, and different ailments in animal specimens presented by veterinary specialists. These laboratories use the veterinary diagnostics available in the market to serve pet owners, government-related programs or research collaborations.

The point of care segment is expected to exhibit the fastest growth over the forecast period. The end consumers such as the pet owners are gaining valuable benefits out of the technologically advanced veterinary diagnostics such as in-house analyzers and point of care for their convenience and quick results.

Global veterinary diagnostics market share, by end use, 2020 (%)

The research institutes are also a big force behind the development and usage of veterinary diagnostics. The functions which are governed by the research institutes in relation with the animal diagnosis are, deployment, identification and development of new diagnostic methods or procedures for research and monitoring purposes of newly emerging or existing diseases in animals.

Regional Insights

North America dominated the market for veterinary diagnostics and accounted for the largest revenue share of over 32.0% in 2020 followed by Europe. There has been a significant rise in veterinary healthcare expenditure in the region, which is expected to accelerate the growth of the market. Furthermore, the presence of healthcare programs and rise in the number of initiatives to promote animal health are factors anticipated to increase the growth potential in this region. For instance, the North American Pet Health Insurance Association is focused on increasing awareness about health insurance coverage for pets. Efficient measures undertaken by the animal welfare organizations in case of an emergency or sudden disease outbreak are also expected to contribute towards market growth across North America.

In Asia Pacific, the market for veterinary diagnostics is expected to grow at a faster rate over the forecast period. Rise in middle-class households, increased disposable income, acceptance of pet animals, and high demand for animal proteins are some of the key factors expected to boost growth of the market in the region.

Key Companies & Market Share Insights

The market for veterinary diagnostics is fragmented with many big and small industry players. Key players are adopting business strategies including diverse product offerings, regional expansion, partnerships, and new product launches to gain market share. For instance, in September 2020, Zoetis launched Vetscan Imagyst-a diagnostic platform-to improve its pet diagnostics portfolio. In January 2021, Heska entered into an agreement to acquire Lacuna Diagnostics, Inc. This enabled the company to enter into clinical specialty services space. Some of the prominent players in the veterinary diagnostics market include:

  • Zoetis,

  • Heska Corporation

  • IDEXX Laboratories Inc.

  • Agrolabo S.p.A,

  • IDvet

  • Virbac

  • Thermo Fisher Scientific Inc.

  • Neogen Corporation

  • Covetrus

  • iM3Vet Pty Ltd.

Veterinary Diagnostics Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 6.8 billion

Revenue forecast in 2028

USD 14.6 billion

Growth Rate

CAGR of 11.5% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, species, testing category, disease type, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MiddleEast and Africa

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Japan; India; China; Brazil; Mexico; Argentina; South Africa; Saudi Arabia

Key companies profiled

Zoetis; Heska Corporation; IDEXX Laboratories Inc.; Agrolabo S.p.A; IDvet; Virbac; Thermo Fisher Scientific Inc.; Neogen Corporation; Covetrus; iM3Vet Pty Ltd.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global veterinary diagnostics market report on the basis of product, species, disease type, testing category, end use, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Consumables, Reagents & Kits

    • Instruments & Devices

  • Species Outlook (Revenue, USD Million, 2016 - 2028)

    • Cattle

    • Canine

    • Feline

    • Caprine

    • Equine

    • Ovine

    • Porcine

    • Avian

    • Others

  • Testing Category Outlook (Revenue, USD Million, 2016 - 2028)

    • Analytical Services

    • Diagnostic Imaging

    • Bacteriology

    • Pathology

    • Molecular Diagnostics

    • Immunoassays

    • Parasitology

    • Serology

    • Virology

  • Disease Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Infectious Diseases

    • Non-Infectious Diseases

    • Hereditary, Congenital and Acquired Diseases

    • General Ailments

    • Structural and Functional Diseases

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Laboratories

    • Veterinary Hospitals and Clinics

    • Point-Of-Care/In-House Testing

    • Research Institutes and Universities

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.